Malady Kyle 4

What Happened Kyle Malady, Executive Vice President and Group CEO — VZ Business at Verizon Communications (VZ), was granted 126.219 phantom shares (derivative award) on 2026-05-21. The award was recorded at a per‑share value of $13.77, for a total economic value of approximately $1,738. This was an award/acquisition (derivative phantom stock), not an open‑market buy or sale of actual common shares.

Key Details

• Transaction date and type: 2026-05-21 — Grant/acquisition of phantom stock (code A).
• Price/value: 126.219 phantom shares at $13.77 each; total ≈ $1,738.
• Filing date: Form 4 filed 2026-05-26 (the filing occurred five days after the transaction date; check the Form 4 timeliness flag for official status).
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Footnotes: F1 — each phantom share is cash‑settled and payable under the deferred compensation plan; F2 — amount includes phantom stock acquired through dividend reinvestment.

Context Phantom stock is a deferred compensation derivative that mirrors the economic value of common stock but is settled in cash (not actual share issuance). Such grants are routine for executive compensation and do not directly change the company’s outstanding shares. This transaction represents receipt of a cash‑settled award, not a market purchase or sale.